$7.78
0.030.39%
At close: -
$7.78
0.000.00%
After Hours: Dec 20, 4:36 PM EDT
Amneal Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Amneal Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-08 | $0.16 | $0.13 | 23.1 % |
Jun 2024 | 2024-08-09 | $0.16 | $0.14 | 14.3 % |
Mar 2024 | 2024-05-03 | $0.14 | $0.09 | 55.6 % |
Dec 2023 | 2024-03-01 | $0.14 | $0.09 | 55.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-08 | $702.47M | $696.80M | 0.81 % |
Jun 2024 | 2024-08-09 | $701.78M | $658.14M | 6.63 % |
Mar 2024 | 2024-05-03 | $659.19M | $619.03M | 6.49 % |
Dec 2023 | 2024-03-01 | $616.98M | $634.23M | -2.72 % |
Amneal Pharmaceuticals (AMRX) is scheduled to report earnings on February 28, 2025. The last reported earnings were for reported on November 8, 2024 for Q3.
The Actual EPS was $0.16, which beat the estimate of $0.13.
The Actual Revenue was $702.5M, which beat the estimate of $696.8M.
Browse earnings estimates, EPS, and revenue on all stocks.